This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $34,922.95, is for the supply of 4,565,781,570 units of the pharmaceutical product Deferasirox 360 mg Tablet. The contract has an ultimate completion date of September 13, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,583.96, is a Delivery Order for the supply of 4,566,199 units of the drug Deferasirox 360 mg Tablet, packaged in 30s. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a completion date of February 1, 2024 and a potential value of $2,946.36. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a major...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Deferasirox 360 mg tablets, a medication used to treat chronic iron overload conditions. The award has a ceiling value of $16,434.54 and a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEFERASIROX 360 MG TABLET 30S, a medical product, with a ceiling value of $54,663.84 and a performance period through May 20, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DEFERASIROX 360 MG TABLET 30S, a pharmaceutical product, and has a firm fixed price of $33,786.47. The contract has an ultimate completion date of May 23, 2025 and was awarded on May 22, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, with a ceiling value of $34,899.12, is for the provision of Deferiprone 500 mg tablets to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of...
This is a firm fixed price delivery order for 360mg Deferasirox tablets awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $52,303.36 contract has a completion date of January 18, 2024 and was awarded on January 17, 2024. There was no set-aside designation used for this award. As a prime contractor, AmerisourceBergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Deferiprone 1,000 MG Tablets (3 times per day, 50 tablets per order) with a ceiling value of $42,634.83 and a completion date of December 11, 2024. The contract is a delivery order awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...